Analysis of the cytokine profile in serum of mice further confirmed that the inflammatory markers (including TNF-α, IL-1β, IL-6, IL-12, and MCP-1) were extensively and dramatically decreased in pSAP-treated lupus mice as compared with other control groups (Fig. 6C). The gene discussed is CCL2; the disease is systemic lupus erythematosus.